Bitcoin Below 100000 Market Dynamics and Investor Considerations Oil Prices Edge Higher as USIran Talks Show Limited Progress Wall Street Indexes Edge Higher as Middle East Peace Hopes Buoy Investor Sentiment Jim Cramer Expresses Disappointment Over Toll Brothers Outlook NASA Taps Blue Origin for First Lunar Mission in 20B Moon Base Plan Global Equities Hit Record Highs on AI Optimism but Dalal Street Struggles Under Geopolitical and Oil Pressure Nano Nuclear Energy Inc NNE Q1 2026 Earnings NarrowerThanExpected Loss Drives 347 EPS Surprise Stock Slips 59 ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline EGO Q1 2026 Earnings EPS Surges Past Estimates by 33 Amid Operational Gains RANI Q1 2026 Earnings SmallerThanExpected Loss Drives Positive Stock Reaction Energy Services of America Corporation ESOA Q1 2026 Earnings EPS Surges Past Estimates by 743 Despite Stock Pullback Genie Energy Ltd GNE Q1 2026 Earnings EPS Falls Short of Estimates Amidst Operational Headwinds ATRenew RERE Slips 5 as Support Level Comes into Focus Hershey HSY Gains Nearly 4 as Confectionery Giant Tests Key Resistance Youxin Technology Ltd YAAS Edges Higher as Price Approaches Resistance Inspire Medical Systems INSP Holds Steady Near 42 as Support and Resistance Define a Tight Trading Range Central Puerto CEPU Springs Over 6 as Bullish Momentum Builds Enbridge Receives Higher Price Target as Cash Flow Strength Continues OLP Q1 2026 Earnings EPS Beats Estimates by 66 Revenue Details Not Disclosed Globus Maritime GLBS Nears Support After 195 Decline Key Levels for Traders to Monitor Fermi Inc FRMI Posts Modest Gains as Stock Holds Above Key Support Cayson Acquisition Corp CAPN Holds Steady at 1078 Amid Low Volume Potential Support and Resistance Levels to Watch CVD Equipment Corporation CVV Slides 537 as Shares Test Key Support Level WSFS Financial Corp WSFS Slips 116 as Banking Sector Faces Headwinds Sharps Technology Inc Warrant STSSW Holds Steady at 004 Amid Low Volatility Cinemark Holdings CNK Holds Near Key Support Amid Modest Decline Beam Therapeutics BEAM Rises 35 as Gene Editing Sector Gains Traction